Martin Shkreli (Dennis Van Tine/Sipa USA)(Sipa via AP Images)

Nine years and four gener­ics lat­er, the HIV drug at the cen­ter of the Shkre­li con­tro­ver­sy still has a high price

Years af­ter Mar­tin Shkre­li kicked off a drug pric­ing con­tro­ver­sy around the HIV drug Dara­prim, the price of the drug has not fall­en to pre …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.